First report 2h ago•Last update 2h ago
Discussion on EMA Transparency Deficits
A video discusses transparency deficits at the European Medicines Agency (EMA), touching on issues of ignorance, cover-ups, deception, and redaction.
Background
The European Medicines Agency (EMA) is responsible for the scientific evaluation, supervision, and safety monitoring of medicines in the European Union. Its operations and decision-making processes have been subject to ongoing scrutiny regarding transparency and public accountability, particularly concerning data access and potential conflicts of interest.
Quorum · collective opinions
Discussion on EMA Transparency Deficits
First report 3h agoLast update 3h ago1 takes▼ 1
criticism of ema transparencynegativeShow 1 post
started 3h ago•Last update 3h ago
Concerns are raised about a lack of transparency, including potential cover-ups and deception, at the EMA.
iWitness comments
No comments yet — be the first to weigh in.